Rethink mRNA-based Discovery Workflows with the Power of Automated Synthetic Biology
On-Demand Webinar Request
Rethink mRNA-based Discovery Workflows with the Power of Automated Synthetic Biology
The success of mRNA-based COVID-19 vaccines has resulted in increased opportunity for advancing mRNA as a platform for vaccine and therapeutic discovery.
This momentum brings to the forefront a need for optimizing mRNA-based discovery and development workflows. A key bottleneck in discovery workflows is acquiring synthetic mRNA for screening, validation, and optimization of candidates. Request our on-demand webinar to learn more about:
- How synthetic mRNA solutions can accelerate adoptive T-cell therapy and vaccine discovery workflows
- How to overcome traditional synthetic mRNA bottlenecks and build hundreds of candidates a week for screening and optimization
- How automating mRNA synthesis is key to advancing speed, efficiency and scope of mRNA-based discovery workflows
Presented by:
Krishna Kannan, PhD.
Senior Director, Product Development
Telesis Bio
"*" indicates required fields
By clicking submit, you agree that Telesis Bio may use this information to contact you about our programs, products, or services. You may opt out at any time.
Your personal data is handled according to our privacy policy. In addition, if you are located within a distributor territory, you may be contacted directly by them. We never sell your data to anyone.